Q-omics provides the consensus-scored RPS23P7 profile across patient tissues and cancer cell-line models. RPS23P7 expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in HNSC. Among the 18 cancer types available for tumor–normal comparison, RPS23P7 is differentially expressed in 1, with the highest sampling consensus in THCA. Additionally, RPS23P7 RNA expression shows 6,542 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight HNSC, THCA, and STAD as cancer lineages where RPS23P7 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RPS23P7 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RPS23P7 survival associations across molecular data types. RPS23P7 RNA expression shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RPS23P7 RNA expression–survival associations across cancer types. High RPS23P7 expression shows unfavorable associations in KIRC, KIRP, BRCA and OV, but favorable associations in HNSC and COAD. The HNSC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .004). Together, the overview and detailed table identify HNSC as the clearest survival context for RPS23P7 RNA expression.
This table summarizes RPS23P7 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for RPS23P7. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RPS23P7 shows lower tumor expression in THCA. The THCA box plot shows higher RPS23P7 RNA expression in normal versus tumor tissue (log2 FC = −0.040, t-test p = .026).
This table shows molecular features associated with RPS23P7 in patient tissues and cancer cell lines. In patient samples, RPS23P7 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
